Rocuronium Bromide Injection
Product Images NDC 71288-700

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71288-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Rocuronium Bromide Injection 100 mg Per 10 mL Carton (Rocuronium 100mg Carton)

Flat packaging label for Rocuronium Bromide Injection 100 mg per 10 mL (10 mg per mL) by Meitheal Pharmaceuticals Inc. The label shows dosage form as injection for intravenous use, with warnings about paralyzing agent and respiratory arrest. The label includes storage, usage instructions, barcode, and manufacturer information.*

FDA Label Image

Principal Display Panel – Rocuronium Bromide Injection 100 mg Per 10 mL Vial Label (Rocuronium 100mg Vial)

Rocuronium Bromide Injection 100 mg per 10 mL (10 mg/mL) label for intravenous use. Features warnings regarding its paralyzing agent effect and instructions for storage at 2 to 8 °C. It is a 10 mL multi-dose vial manufactured by Meitheal Pharmaceuticals Inc., Chicago, IL, USA.*

FDA Label Image

Principal Display Panel – Rocuronium Bromide Injection 50 mg Per 5 mL Carton (Rocuronium 50mg Carton)

Packaging label for Rocuronium Bromide Injection 50 mg per 5 mL (10 mg per mL) by Meitheal Pharmaceuticals Inc. The label specifies the drug as a paralyzing agent for intravenous use only, presented in 5 mL multi-dose vials (10 vials per package). It includes storage directions, usage warnings, and manufacturing details.*

FDA Label Image

Principal Display Panel – Rocuronium Bromide Injection 50 mg Per 5 mL Vial Label (Rocuronium 50mg Vial)

Label for Rocuronium Bromide Injection, 10 mg/mL (50 mg per 5 mL), in a 5 mL multi-dose vial. The label indicates it is a paralyzing agent for intravenous use only, sterile, nonpyrogenic, and preservative-free. The labeler is Meitheal Pharmaceuticals Inc., Chicago, IL, USA.*

FDA Label Image

Figure 1 (Rocuronium Fig 1)

A box plot chart displaying data on drug dosage across three age groups (18-64 years, 65 years and older, and 1-12 years) with dosage levels in mg/kg on the x-axis and time in minutes on the y-axis. The chart shows variability and outliers in response times across different dosages and age groups.*

FDA Label Image

Figure 2 (Rocuronium Fig 2)

A box plot chart showing distribution of minutes for different age groups (18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years) at various dosages measured in mg/kg. The chart includes individual data points, medians, and interquartile ranges for each group and dosage combination.*

FDA Label Image

Figure 3 (Rocuronium Fig 3)

A line chart depicting time in minutes on the vertical axis and dose number on the horizontal axis. The graph shows two dose groups, 0.15 mg/kg and 0.1 mg/kg, with respective sample sizes of 13 and 29, tracking their time measurements across five dose numbers.*

FDA Label Image

Structural Formula (Rocuronium Structure)

Chemical structure of Rocuronium Bromide showing its molecular framework including rings, functional groups, and a bromide ion (Br-). The structure is depicted with bond angles and stereochemistry for the active ingredient Rocuronium Bromide.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.